Abstract: The present invention relates to methods and devices for carrying out cryogenic therapy, particularly on the whole body of a patient, wherein the patient is exposed to gases cooled to cryogenic temperature. The process is performed by introducing the patient into the interior of a treatment cabin and exposing the body to cold air deposited into the cabin space.

Abstract: The present invention relates to methods and devices for carrying out cryogenic therapy, particularly on the whole body of a patient, wherein the patient is exposed to gases cooled to cryogenic temperature. The process is performed by introducing the patient into the interior of a treatment cabin and exposing the body to cold air deposited into the cabin space.

Abstract: Method of carrying out the cryogenic therapy, particularly on the whole body of one or several patient/s, characterized in that said patient/s are introduced along a transport route through the upper part of a chamber and then through the interior of said chamber, wherein said chamber has thermally insulated walls and a space containing a deposited low temperature cooling agent. The patient/s are then led to a cryogenic treatment cabin having a very low temperature from ?60.c to ?160.c with exposure times ranging from 0.5 to 5 minutes, whereafter said patient/s leave said treatment cabin through the interior of said chamber and further along said transport route outside chamber to an area at room temperature. The corresponding device for carrying out cryogenic therapy is characterized by a chamber with an open upper part and by a separated cryogenic treatment cabin inside said chamber said cabin being cooled in its whole volume by a cooling agent in the form of liquid air sprayed by nozzles.

Abstract: Method of carrying out the cryogenic therapy, particularly on the whole body of one or several patient/s, characterized in that said patient/s are introduced along a transport route (1) through the upper part (2) of a chamber (3) and then through the interior (4) of said chamber (3), wherein said chamber (3) has thermally insulated walls (5) and a space containing a deposited low temperature cooling agent. The patient/s are then led to a cryogenic treatment cabin (6) having a very low temperature from ?60.c to ?160.c with exposure times ranging from 0.5 to 5 minutes, whereafter said patient/s leave said treatment cabin (6) through the interior (4) of said chamber (3) and further along said transport route (1) outside chamber (3) to an area at room temperature.